The Biden administration on June 21 announced how it would allocate 55 million of the 80 million doses of its vaccine supply to other countries. It is not known how many doses India will receive in this second allocation.
The administration has already outlined its plans to share the first 25 million doses from its stockpile both bilaterally and through global access to COVID-19 vaccines, abbreviated COVAX – an international coalition to distribute vaccines globally. Three quarters of the 80 million are shared via COVAX and a quarter directly. Of the 80 million, 60 million are AstraZeneca vaccines, not yet approved for use in the United States
Of the 55 million doses, 41 million will be shared via COVAX. Of this amount, about 14 million will go to Asian countries, including India, about 10 million to Africa (coordinated by the African Union) and about 16 million to Latin American countries. 14 million additional doses will be shared “with regional priorities and other recipients,” according to the White House statement. This includes countries in Africa, Asia, Eastern Europe and South America as well as three countries in South Asia – Afghanistan, Bangladesh and Pakistan. The specific number of vaccines will be determined and shared as the administration works on the logistical and regulatory specifics of each region, the White House said.
At the G7 in the UK last week, President Joe Biden announced that the US will purchase and donate 500 million doses of the Pfizer-BioNTech vaccine to low- and middle-income countries. The G7 has also pledged to deliver a total of 1 billion doses of vaccine starting this summer. The World Health Organization (WHO) has estimated that the world needs 11 billion vaccines to respond to the pandemic.